SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 84.01 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | -6.64 |
| Book Value / Share | -0.04 |
| Price / Book | n/a |
| NCAV ($M) | -20.47 |
| NCAV / Share | -0.11 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -7.45 |
| Return on Assets (ROA) | -0.25 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.33 |
| Current Ratio | 0.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 12.13 |
| Assets | 25.95 |
| Liabilities | 32.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 15.65 |
| Operating Income | -6.49 |
| Net Income | -6.67 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -2.10 |
| Cash from Investing | 1.66 |
| Cash from Financing | 1.52 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| PXMD – PaxMedica, Inc. | PXXLF – Poxel S.A. |
| PXYN – Praxsyn Corporation | QBIO – Q BioMed Inc. |
| QNNTF – Quantum Genomics Société Anonyme |
Financial data and stock pages provided by
Fintel.io